Logo

Helius Medical Technologies Reported Results for its Portable Neuromodulation Stimulator (PoNS) Therapy in Patients Suffering from Traumatic Brain Injury (TBI)

Share this
Helius Medical

Helius Medical Technologies Reported Results for its Portable Neuromodulation Stimulator (PoNS) Therapy in Patients Suffering from Traumatic Brain Injury (TBI)

Shots:

  • The study evaluates the occupational performance & durabale Return-to-Work (RTW) status in patients (n=9) with TBI receiving the PoNS Therapy for a duration of 6mos. while patients perform rehabilitation exercises
  • The results showed that 56% of the patients RTW, 80% returned to their prior full-time jobs for at least 6mos., 67% showed improvement in their balance & gait, in 89% balance & gait did not affect RTW & of patients facing headaches as a prevention to RTW, 50% reported a reduction in headache intensity
  • PoNS is an orally applied therapy that delivers neurostimulation (to the tongue) through a controlled mouthpiece & is used with physical rehabilitation exercises, to improve balance & gait

Ref: Globenewswire | Image:  Helius Medical Technologies

Related News:- Abbott Reports Positive Data of its Blood Test Technology Detecting Traumatic Brain Injury in Patients with Negative CT Scan 

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Shivani Chandra

Shivani was a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She was covering news related to Product approvals, clinical trial results, and updates. We can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions